Oncology and Chemotherapy Department, Lishui People's Hospital, Lishui, China.
Department of Orthopedics, Yunhe People's Hospital, Lishui, China.
Front Endocrinol (Lausanne). 2024 May 21;15:1367916. doi: 10.3389/fendo.2024.1367916. eCollection 2024.
The optimal resuscitative fluid for patients with diabetic ketoacidosis (DKA) remains controversial. Therefore, our objective was to assess the effect of balanced crystalloids in contrast to normal saline on clinical outcomes among patients with DKA.
We searched electronic databases for randomized controlled trials comparing balanced crystalloids versus normal saline in patients with DKA, the search period was from inception through October 20, 2023. The outcomes were the time to resolution of DKA, major adverse kidney events, post-resuscitation chloride, and incidence of hypokalemia.
Our meta-analysis encompassed 11 trials, incorporating a total of 753 patients with DKA. There was no significant difference between balanced crystalloids and normal saline group for the time to resolution of DKA (MD -1.49, 95%CI -4.29 to 1.31, P=0.30, I = 65%), major adverse kidney events (RR 0.88, 95%CI 0.58 to 1.34, P=0.56, I = 0%), and incidence of hypokalemia (RR 0.80, 95%CI 0.43 to 1.46, P=0.46, I = 56%). However, there was a significant reduction in the post-resuscitation chloride (MD -3.16, 95%CI -5.82 to -0.49, P=0.02, I = 73%) among patients received balanced crystalloids.
Among patients with DKA, the use of balanced crystalloids as compared to normal saline has no effect on the time to resolution of DKA, major adverse kidney events, and incidence of hypokalemia. However, the use of balanced crystalloids could reduce the post-resuscitation chloride.
https://osf.io, identifier c8f3d.
对于糖尿病酮症酸中毒(DKA)患者而言,最佳复苏液仍存在争议。因此,我们的目的是评估平衡晶体液与生理盐水相比对 DKA 患者临床结局的影响。
我们检索了电子数据库,以评估比较 DKA 患者中平衡晶体液与生理盐水的随机对照试验,检索时间为从开始至 2023 年 10 月 20 日。主要结局为 DKA 缓解时间、主要不良肾脏事件、复苏后血氯和低钾血症的发生率。
我们的荟萃分析共纳入 11 项试验,共纳入 753 例 DKA 患者。平衡晶体液与生理盐水组在 DKA 缓解时间(MD -1.49,95%CI -4.29 至 1.31,P=0.30,I = 65%)、主要不良肾脏事件(RR 0.88,95%CI 0.58 至 1.34,P=0.56,I = 0%)和低钾血症的发生率(RR 0.80,95%CI 0.43 至 1.46,P=0.46,I = 56%)方面无显著差异。然而,接受平衡晶体液治疗的患者复苏后血氯显著降低(MD -3.16,95%CI -5.82 至 -0.49,P=0.02,I = 73%)。
在 DKA 患者中,与生理盐水相比,使用平衡晶体液对 DKA 缓解时间、主要不良肾脏事件和低钾血症的发生率无影响。然而,使用平衡晶体液可能会降低复苏后的血氯。
https://osf.io,标识符 c8f3d。